This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, S. L. Articles by Xu, J. Search for Related Content PubMed PubMed Citation Articles by Zheng, S. L. Articles by Xu, J.

Germ-Line Mutation of NKX3.1 Cosegregates with Hereditary Prostate Cancer and Alters the Homeodomain Structure and Function

¹ Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina; ² Departments of Oncology and Medicine, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia; ³ Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and ⁴ Laboratory of Biophysical Chemistry, National Heart, Lung, and Blood Institute, Bethesda, Maryland

Requests for reprints: William B. Isaacs, Department of Urology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Marburg 115, Baltimore, MD 21287. Phone: 410-955-2518; Fax: 410-955-0833; E-mail: wisaacs{at}jhmi.edu.

NKX3.1, a gene mapped to 8p21, is a member of the NK class of homeodomain proteins and is expressed primarily in the prostate. NKX3.1 exerts a growth-suppressive and differentiating effect on prostate epithelial cells. Because of its known functions and its location within a chromosomal region where evidence for prostate cancer linkage and somatic loss of heterozygosity is found, we hypothesize that sequence variants in the NKX3.1 gene increase prostate cancer risk. To address this, we first resequenced the NKX3.1 gene in 159 probands of hereditary prostate cancer families recruited at Johns Hopkins Hospital; each family has at least three first-degree relatives affected with prostate cancer. Twenty-one germ-line variants were identified in this analysis, including one previously described common nonsynonymous change (R52C), two novel rare nonsynonymous changes (A17T and T164A), and a novel common 18-bp deletion in the promoter. Overall, the germ-line variants were significantly linked to prostate cancer, with a peak heterogeneity logarithm of odds of 2.04 (P = 0.002) at the NKX3.1 gene. The rare nonsynonymous change, T164A, located in the homeobox domain of the gene, segregated with prostate cancer in a family with three affected brothers and one unaffected brother. Importantly, nuclear magnetic resonance solution structure analysis and circular dichroism studies showed this specific mutation to affect the stability of the homeodomain of the NKX3.1 protein and decreased binding to its cognate DNA recognition sequence. These results suggest that germ-line sequence variants in NKX3.1 may play a role in susceptibility to hereditary prostate cancer and underscore a role for NKX3.1 as a prostate cancer gatekeeper. (Cancer Res 2006; 66(1): 69-77)

This article has been cited by other articles:

				B.-l. Chang, W. Liu, J. Sun, L. Dimitrov, T. Li, A. R. Turner, S. L. Zheng, W. B. Isaacs, and J. Xu Integration of Somatic Deletion Analysis of Prostate Cancers and Germline Linkage Analysis of Prostate Cancer Families Reveals Two Small Consensus Regions for Prostate Cancer Genes at 8p Cancer Res., May 1, 2007; 67(9): 4098 - 4103. [Abstract] [Full Text] [PDF]

				C. Bowen, A. Stuart, J.-H. Ju, J. Tuan, J. Blonder, T. P. Conrads, T. D. Veenstra, and E. P. Gelmann NKX3.1 Homeodomain Protein Binds to Topoisomerase I and Enhances Its Activity Cancer Res., January 15, 2007; 67(2): 455 - 464. [Abstract] [Full Text] [PDF]

				S. R. Morey, D. J. Smiraglia, S. R. James, J. Yu, M. T. Moser, B. A. Foster, and A. R. Karpf DNA Methylation Pathway Alterations in an Autochthonous Murine Model of Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11659 - 11667. [Abstract] [Full Text] [PDF]